Oryzon Genomics S.A. (ORYZF)

USD 1.79

(0.0%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 106.9 Million 103.69 Million 95.38 Million 94.1 Million 80.09 Million 67.45 Million
Total Current Assets 14.27 Million 25.16 Million 32.6 Million 42.37 Million 37.73 Million 35.66 Million
Cash And Short Term Investments 12.25 Million 21.31 Million 28.72 Million 39.6 Million 35.11 Million 34.46 Million
Cash and Cash Equivalents 12.25 Million 21.31 Million 28.72 Million 39.6 Million 35.11 Million 34.31 Million
Short Term Investments - - - -40.5 Thousand 141.55 Thousand 141.55 Thousand
Net Receivables - 4.1 Million 1.47 Million 1.41 Million 1.49 Million 1.22 Million
Inventory 6029.00 9798.00 103.79 Thousand 316.83 Thousand 288.8 Thousand 134.5 Thousand
Other Current Assets 2.01 Million -269.63 Thousand 2.82 Million 1.58 Million 970.31 Thousand 161.81 Thousand
Total Non-Current Assets 92.62 Million 78.53 Million 62.77 Million 51.72 Million 42.35 Million 31.78 Million
Net PPE 481.28 Thousand 611.42 Thousand 682.42 Thousand 643.92 Thousand 631.28 Thousand 664.9 Thousand
Good Will And Intangible Assets 89.89 Million 75.84 Million 60.25 Million 49.21 Million 39.93 Million 29.32 Million
Good Will - - - - - -
Intangible Assets 89.89 Million 75.84 Million 60.25 Million 49.21 Million 39.93 Million 29.32 Million
Long-Term Investments - 32.66 Thousand 33.52 Thousand 81.3 Thousand 75.15 Thousand 76.49 Thousand
Tax Assets 2.22 Million 2.05 Million 1.81 Million 1.8 Million 1.72 Million 1.72 Million
Other Non Current Assets 25.8 Thousand -2143.00 -4030.00 -14.85 Thousand -8201.00 -9577.00
Other Assets - 0.00 - -0.00 -0.00 -
Total Liabilities 25.12 Million 31.12 Million 24.12 Million 18.17 Million 18.96 Million 22.32 Million
Total Current Liabilities 16.41 Million 18.73 Million 8.67 Million 7.69 Million 10.54 Million 10.44 Million
Account Payables 3.41 Million 5.06 Million 2.9 Million 2 Million 3.26 Million 1.6 Million
Tax Payables 204.16 Thousand 208.86 Thousand 212.01 Thousand 218.97 Thousand 196.03 Thousand 214.35 Thousand
Short Term Debt 10.23 Million 10.38 Million 3.42 Million 3.79 Million 5.69 Million 7.43 Million
Deferred Revenue - 3.21 Million 2.26 Million 1.81 Million 1.5 Million 1.14 Million
Other Current Liabilities 2.76 Million 73.94 Thousand 70.25 Thousand 78.72 Thousand 79.38 Thousand 253.48 Thousand
Total Non Current Liabilities 8.71 Million 12.39 Million 15.45 Million 10.48 Million 8.41 Million 11.88 Million
Long-Term Debt 3.45 Million 7.06 Million 10.34 Million 5.3 Million 3.78 Million 7.39 Million
Deferred Revenue Non Current - - 2.96 Million - - 2.76 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.03 Million 3.28 Million 323.86 Thousand 3.37 Million 2.91 Million 1.00
Other Liabilities - - - - -0.00 -
Total Equity 81.77 Million 72.57 Million 71.26 Million 75.93 Million 61.12 Million 45.12 Million
Stock Holders Equity 81.77 Million 72.57 Million 71.26 Million 75.93 Million 61.12 Million 45.12 Million
Common Stock 3.05 Million 2.77 Million 2.65 Million 2.65 Million 2.28 Million 1.95 Million
Retained Earnings -15.67 Million -12.31 Million -8.08 Million -3.39 Million -19.5 Million -15.91 Million
Accumulated other comprehensive income 2.5 Million 87.59 Million 86.29 Million 92.89 Million 91.79 Million 69.65 Million
Common Stock Equity 81.77 Million 72.57 Million 71.26 Million 75.93 Million 61.12 Million 45.12 Million
Capital Lease Obligation 78.62 Thousand 99.09 Thousand - - - -
Total Investments - 32.66 Thousand 33.52 Thousand 40.8 Thousand 40.8 Thousand 66.91 Thousand
Total Debt 13.68 Million 17.44 Million 13.77 Million 9.09 Million 9.47 Million 14.82 Million
Net Debt 1.43 Million -3.87 Million -14.95 Million -30.51 Million -25.63 Million -19.49 Million

Balance Sheet Charts